Want to see IN:VISHNU full AI Analyst Report?
Top Page
Vishnu Chemicals Limited
(VISHNU)
Select Model
Select Model
Rating:63Neutral
Price Target:
₹659.00
▲(16.07% Upside)
Action:Reiterated
Date:06/02/26
The score is anchored by mixed fundamentals: solid profitability and improved leverage are offset by materially weak cash conversion and multi-year negative free cash flow. Technicals are supportive with a clear uptrend and positive momentum, while valuation is balanced by a high P/E versus a strong dividend yield.
Positive Factors
End-market Diversification
Exposure to multiple industrial end markets (pharma, pigments, leather, metal finishing) and both domestic and export customers supports demand resilience and reduces single-market cyclicality. This broad end-market mix helps stabilize volumes and provides cross-sector pricing levers over a multi-month horizon.
Negative Factors
Weak Cash Conversion
Persistent negative free cash flow and operating cash well below reported profits imply weak cash conversion from earnings, likely due to capex or working-capital build. That pattern raises funding risk, increases reliance on debt, and limits ability to self-fund growth or cushion shocks over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
End-market Diversification
Exposure to multiple industrial end markets (pharma, pigments, leather, metal finishing) and both domestic and export customers supports demand resilience and reduces single-market cyclicality. This broad end-market mix helps stabilize volumes and provides cross-sector pricing levers over a multi-month horizon.
Read all positive factors
Vishnu Chemicals Limited (VISHNU) vs. iShares MSCI India ETF (INDA)
Market Cap
₹40.42B
Dividend Yield0.05%
Average Volume (3M)8.04K
Price to Earnings (P/E)28.9
Beta (1Y)0.69
Revenue Growth11.28%
EPS Growth10.48%
CountryIN
Employees464
SectorGeneral
Sector StrengthN/A
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)21.19
Shares Outstanding67,315,285
10 Day Avg. Volume5,038
30 Day Avg. Volume8,045
Financial Highlights & Ratios
PEG Ratio2.33
Price to Book (P/B)3.08
Price to Sales (P/S)2.04
P/FCF Ratio-20.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.5
Revenue Forecast (FY)₹17.92B
Vishnu Chemicals Limited Business Overview & Revenue Model
Company Description
Founded in 1989 and headquartered in Hyderabad, India, Vishnu Chemicals Limited specializes in the manufacturing and global distribution of chromium and barium compounds. The company's extensive product line features various chrome-based chemicals...
How the Company Makes Money
Vishnu Chemicals primarily makes money by manufacturing and selling specialty chemicals—especially chromium-based chemicals (such as chromium salts and related intermediates)—to industrial customers. Revenue is generated through: (1) domestic and ...
Vishnu Chemicals Limited Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
67
Positive
Cash Flow
38
Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 16.10B | 14.47B | 12.09B | 13.88B | 10.66B |
| Gross Profit | 3.99B | 3.58B | 2.93B | 4.93B | 3.86B |
| EBITDA | 2.52B | 2.44B | 2.05B | 2.44B | 1.60B |
| Net Income | 1.42B | 1.27B | 1.01B | 1.37B | 813.93M |
Balance Sheet | |||||
| Total Assets | 20.88B | 16.34B | 13.25B | 10.51B | 9.15B |
| Cash, Cash Equivalents and Short-Term Investments | 1.00B | 817.44M | 617.07M | 20.93M | 27.99M |
| Total Debt | 5.27B | 3.42B | 3.19B | 3.79B | 3.65B |
| Total Liabilities | 10.13B | 7.07B | 6.24B | 6.37B | 6.38B |
| Stockholders Equity | 10.69B | 9.27B | 7.01B | 4.14B | 2.77B |
Cash Flow | |||||
| Free Cash Flow | -1.64B | -263.28M | -528.47M | 168.85M | 64.28M |
| Operating Cash Flow | 933.10M | 615.23M | 674.98M | 1.34B | 897.27M |
| Investing Cash Flow | -2.71B | -1.07B | -1.54B | -1.18B | -811.50M |
| Financing Cash Flow | 1.83B | 462.23M | 881.28M | -155.73M | -85.66M |
Vishnu Chemicals Limited Technical Analysis
Positive
567.75
Price Trends
600.43
Positive
562.38
Positive
533.90
Positive
Market Momentum
1.74
Positive
53.14
Neutral
38.34
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:VISHNU, the sentiment is Positive. The current price of 567.75 is below the 20-day moving average (MA) of 608.05, below the 50-day MA of 600.43, and above the 200-day MA of 533.90, indicating a bullish trend. The MACD of 1.74 indicates Positive momentum. The RSI at 53.14 is Neutral, neither overbought nor oversold. The STOCH value of 38.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:VISHNU.
Vishnu Chemicals Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ₹42.13B | 11.70 | ― | 0.65% | 44.79% | 14.20% | |
64 Neutral | ₹29.25B | 19.57 | ― | 0.09% | 15.19% | 9.27% | |
63 Neutral | ₹40.42B | 28.89 | ― | 0.05% | 11.28% | 10.48% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
51 Neutral | ₹56.50B | 197.17 | ― | 0.09% | 10.86% | -17.60% | |
49 Neutral | ₹32.52B | 78.54 | ― | 0.07% | 32.18% | 636.02% | |
48 Neutral | ₹45.46B | 58.30 | ― | 0.29% | -4.65% | -30.36% |
* General Sector Average
IN:VISHNU
Vishnu Chemicals Limited
611.60
102.97
20.24%
IN:FCL
Fineotex Chemical Limited
35.75
7.94
28.55%
IN:LXCHEM
Laxmi Organic Industries Ltd.
167.50
-34.69
-17.16%
IN:NEOGEN
Neogen Chemicals Ltd.
2,148.70
538.28
33.42%
IN:ROSSARI
Rossari Biotech Ltd
525.70
-207.54
-28.30%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,414.95
470.94
49.89%
Vishnu Chemicals Limited Corporate Events
Vishnu Chemicals Publishes FY26 Audited Results Notice in Newspapers
May 31, 2026
Vishnu Chemicals Limited has published a statutory newspaper advertisement disclosing its audited standalone and consolidated financial results for the fourth quarter and full financial year ended March 31, 2026. The results notice appeared in The...
Vishnu Chemicals Warns Investors on Transfer of Unclaimed Shares to IEPF
Apr 30, 2026
Vishnu Chemicals has notified shareholders and stock exchanges that it has issued individual letters and newspaper advertisements regarding the impending transfer of certain equity shares to the Investor Education and Protection Fund. The move tar...
Vishnu Chemicals Shareholders Approve Re-Appointment of Joint Managing Director via Postal Ballot
Apr 24, 2026
Vishnu Chemicals Limited has announced the results of a postal ballot conducted through remote e-voting, concerning the special business of re-appointing Mr. Ch. Siddartha as Joint Managing Director for a further five-year term from May 2, 2026 to...
Vishnu Chemicals Schedules Virtual Investor Meet on April 13
Apr 8, 2026
Vishnu Chemicals Limited has notified the stock exchanges that it will hold a virtual meeting with analysts and institutional investors on April 13, 2026, starting at 10 a.m. onwards. The company emphasized that no unpublished price-sensitive info...
Vishnu Chemicals Closes Trading Window Ahead of FY26 Results
Mar 23, 2026
Vishnu Chemicals Limited has announced the closure of its trading window for designated persons and their immediate relatives from April 1, 2026, until 48 hours after the board meeting that will consider and approve the audited financial results f...
Vishnu Chemicals Seeks Shareholder Nod to Reappoint Joint Managing Director via Postal Ballot
Mar 12, 2026
Vishnu Chemicals Limited’s board has approved a postal ballot process to seek shareholder approval via special resolution for the reappointment of Mr. Ch. Siddartha as Joint Managing Director for a further five-year term from May 2, 2026, to...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.